BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Idorsia initiates pivotal Phase 3 study for lucerastat in Fabry disease and enters co-development and commercialization agreement with Nxera

  October 28, 2026

   · 

  15 min read
• Press Releases

  Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma

  October 28, 2026

   · 

  7 min read
• Press Releases

  Dassault Systèmes Takes Its Life Sciences Ambition to the Next Level with a Unified AI Platform Connecting Science, Medicine and Patients

  October 28, 2026

   · 

  4 min read
• Press Releases

  Jiahui Launches International Cell Therapy Center to Expand Global Access to CAR-T Treatment

  October 28, 2026

   · 

  2 min read
• Press Releases

  Sensorion Announces its Participation in the European Society of Gene & Cell Therapy (ESGCT) Annual Congress

  October 28, 2026

   · 

  3 min read
• Press Releases

  Samsung Epis Holdings Reports Third Quarter 2026 Financial Results and Business Update

  October 28, 2026

   · 

  6 min read
• Press Releases

  Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets

  October 28, 2026

   · 

  7 min read
• Press Releases

  Ozelle to Spotlight Scalable AI-Assisted Hematology with O-Cyte 1 at MEDICA 2026

  October 28, 2026

   · 

  2 min read
• Press Releases

  Dr. Bobak Parang Announced as Recipient of Rising Tide/LUNGevity Research Award for Overcoming Drug Resistance

  October 28, 2026

   · 

  4 min read
• Press Releases

  Rakovina Therapeutics and Celvion Therapeutics Complete AI Analysis Identifying Priority Cancer Indications for Brain-Penetrant ATR Inhibitor Program

  October 28, 2026

   · 

  6 min read